Abstract
Background
Obstructive sleep apnea (OSA) is a prevalent disease associated with increased risk of cardiovascular mortality. However, the exact causal relationship is not clear. One of the proposed mechanisms is dyslipidemia.
Aim
To study the effect of continuous positive airway pressure (CPAP) on dyslipidemia in patients with OSA.
Patients and methods
Forty obese patients with OSA were recruited. All patients were subjected to history taking, physical examination, and polysomnography. Fasting blood sugar, liver function, kidney function, and lipid profile were measured after fasting for 14 h. Apnea/hypopnea index and BMI were calculated. The patients then received CPAP treatment during night for 3 months. Polysomnography and laboratory parameters were remeasured after 1 and 3 months of treatment.
Results
The natural correlation between body weight and lipid profile is lost. Apnea/hypopnea index and high-density lipoprotein improved significantly after 1 month and more significantly after 3 months. Triglycerides were lowered after 1 month without more improvement after 3 months. Low-density lipoprotein-cholesterol and total-C did not change after 1 month with significant reduction after 3 months.
Conclusion
Treatment with CPAP improves lipid profile in patients with OSA.
Article PDF
Similar content being viewed by others
References
Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Ann Rev Med 1976; 27: 465–484.
Benjafield A, Valentine K, Ayas N, Eastwood PR, Heinzer RC, Ip MS, et al. Global prevalence of obstructive sleep apnea in adults: estimation using currently available data. Am J Respir Crit Care Med 2018; 197: A3962.
El Awady MES, Hammouda K, Hassan A, El Fotouh ASA. Insomnia and obstructive sleep apnea among Egyptians: a hospital-based study. Egypt J Neurol Psychiatry Neurosurg 2014; 51: 89–95.
Levy P, Ryan S, Oldenburg O, Parati G. Sleep apnoea and the heart. Eur Respir Rev 2013; 22: 333–352.
Dong R, Dong Z, Liu H, Shi F, Du J. Prevalence, risk factors, outcomes, and treatment of obstructive sleep apnea in patients with cerebrovascular disease: a systematic review. J Stroke Cerebrovasc Dis 2018; 27: 1471–1480.
Maeder MT, Schoch OD, Rickli H. A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease. Vasc Health Risk Manag 2016; 85: 12–103.
Ama Moor VJ, Ndongo AS, Ombotto S, Ntone F, Wouamba DE, Ngo NB. Dyslipidemia in patients with a cardiovascular risk and disease at the University Teaching Hospital of Yaounde, Cameroon. Int J Vasc Med 2017; 2017: 6061306.
Adedayo AM, Olafiranye O, Smith D, Hill A, Zizi F, Brown C, et al. Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath 2014; 18: 13–18.
Trzepizur W, Le VM, Meslier N, et al. Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia. Chest 2013; 143: 1584–1589.
Abuzaid AS, Al Ashry HS, Elbadawi A, et al. Meta-analysis of cardiovascular outcomes with continuous positive airway pressure therapy in patients with obstructive sleep apnea. Am J Cardiol 2017; 120: 693–699.
Nadeem R, Singh M, Nida M, Kwon S, Sajid H, Witkowski J, et al. Effect of CPAP treatment for obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 2014; 10: 1295–1302.
Xu H, Yi H, Guan J, Yin S. Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome: a meta-analysis of randomized controlled trials. Atherosclerosis 2014; 234: 446–453.
Ruehland WR, Rochford PD, O’Donoghue FJ, Pierce RJ, Singh P, Thornton AT. The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep 2009; 32: 150–157.
Masa JF, Corral J, Pereira R, Duran-Cantolla J, Cabello M, Hernández-Blasco L, et al. Effectiveness of sequential automatic-manual home respiratory polygraphy scoring. Eur Respir J 2013; 41: 879–887.
Silva LOE, Guimaraes TM, Luz GP, Coelho G, Badke L, Almeida IR, et al. Metabolic profile in patients with mild obstructive sleep apnea. Metab Syndr Relat Disord 2018; 16: 6–12.
Phillips CL, Yee BJ, Marshall NS, Liu PY, Sullivan DR, Grunstein RR. Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a randomized, placebo-controlled crossover trial. Am J Respir Crit Care Med 2011; 184: 355–361.
Gu C, Younas H, Jun JC. Sleep apnea: an overlooked cause of lipotoxicity? Med Hypotheses 2017; 108: 161–165.
Bonsignore MR, Borel AL, Machan E, Grunstein R. Sleep apnoea and metabolic dysfunction. Eur Respir Rev 2013; 22: 353–364.
Chopra S, Rathore A, Younas H, Pham LV, Gu C, Beselman A, et al. Obstructive sleep apnea dynamically increases nocturnal plasma free fatty acids, glucose, and cortisol during sleep. J Clin Endocrinol Metab 2017; 102: 3172–3181.
Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000; 101: 392–397.
Ueno K, Kasai T, Brewer G, Takaya H, Maeno K, Kasagi S, et al. Evaluation of the apnea-hypopnea index determined by the S8 auto-CPAP, a continuous positive airway pressure device, in patients with obstructive sleep apnea-hypopnea syndrome. J Clin Sleep Med 2010; 6: 146–151.
Jiang YQ, Xue JS, Xu J, Zhou ZX, Ji YL. Efficacy of continuous positive airway pressure treatment in treating obstructive sleep apnea hypopnea syndrome associated with carotid arteriosclerosis. Exp Ther Med 2017; 14: 6176–6182.
Stuck BA, Leitzbach S, Maurer JT. Effects of continuous positive airway pressure on apnea-hypopnea index in obstructive sleep apnea based on long-term compliance. Sleep Breath 2012; 16: 467–471.
Drager LF, Tavoni TM, Silva VM, Santos RD, Pedrosa RP, Bortolotto LA, et al. Obstructive sleep apnea and effects of continuous positive airway pressure on triglyceride-rich lipoprotein metabolism. J Lipid Res 2018; 59: 1027–1033.
Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999; 100: 706–712.
Borgel J, Sanner BM, Bittlinsky A, Keskin F, Bartels NK, Buechner N, et al. Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J 2006; 27: 121–127.
Davies RJ, Turner R, Crosby J, Stradling JR. Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring; their comparison with matched controls and response to treatment. J Sleep Res 1994; 3: 180–185.
Lattimore JL, Wilcox I, Skilton M, Langenfeld M, Celermajer DS. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006; 61: 491–495.
Kumor M, Bielicki P, Przybylowski T, Rubinsztajn R, Zielinski J, Chazan R. Three month continuous positive airway pressure (CPAP) therapy decreases serum total and LDL cholesterol, but not homocysteine and leptin concentration in patients with obstructive sleep apnea syndrome (OSAS). Pneumonol Alergol Pol 2011; 79: 173–183.
Lin MT, Lin HH, Lee PL, Weng PH, Lee CC, Lai TC, et al. Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis. Sleep Breath 2015; 19: 809–817.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Shehab-Eldin, W.A., Elhabashy, M. The effect of continuous positive airway pressure on dyslipidemia in patients with obstructive sleep apnea. Egypt J Bronchol 13, 120–124 (2019). https://doi.org/10.4103/ejb.ejb_57_18
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejb.ejb_57_18